Magnesium Blood Sugar Meta-analysis: What the Evidence Says

Quick Answer

Magnesium Blood Sugar Meta-analysis has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 observational study.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Metabolic syndrome (MetS), also known as Syndrome X, is a major risk factor for cardiovascular disease worldwide. [Zhao Pengyu (2026); evidence level 1]
• MetS components typically include abdominal obesity, hypertension, dysregulated glucose metabolism, and dyslipidemia (elevated TG levels and reduced HDL-C levels). [Zhao Pengyu (2026); evidence level 1]
• Type 2 diabetes mellitus (T2DM) is a major metabolic disorder marked by chronic hyperglycemia and a progressive risk of microvascular and macrovascular complications. [Muacevic Alexander (2026); evidence level 3]
• Reduced serum magnesium concentrations have been extensively documented in T2DM patients, and are thought to arise from increased urinary loss, nutritional deficiency, and disrupted homeostasis. [Muacevic Alexander (2026); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For magnesium blood sugar meta-analysis, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Zhao Pengyu (2026). The effect of DASH diet on components of metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials. DOI: 10.3389/fnut.2026.1738410. PMCID: PMC13199047. PMID: 42199758. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13199047/
• Muacevic Alexander (2026). Serum Magnesium Status and Its Association With Glycemic Control in Adults With Type 2 Diabetes: A Cross-Sectional Study From a Tertiary Care Center. DOI: 10.7759/cureus.108056. PMCID: PMC13222117. PMID: 42220770. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13222117/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.